Just this week, the CDC and FDA gave the green light to distribute updated bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5. On this episode, we begin a two-part discussion over the science and rationale behind the new vaccines.

Guest speaker:

Show Notes:

[00:54] How the new vaccine type is different

[01:45] Shorter vaccine approval and turnaround

[02:45] COVID virus mutations and immunity

[04:50] Rationale for alternating vaccines

[05:53] Upcoming human studies

[07:47] Vaccine eligibility

Links | Resources:

To contact Modern Practice: [email protected]

FDA announcement on new vaccine boosters (8-31-22): Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Android

Google Podcasts

Spotify

Stitcher

RSS Feed